Basell Sell Share in Taiwanese Polypropylene Joint Venture

Basell announced today that it has agreed to sell its 36% share in Taiwan Polypropylene Company Ltd (TPP) to Lee Chang Yung Chemical Industry Corporation of Taiwan. In conjunction with the sale, Basell will acquire all shares currently held by TPP in other Basell joint ventures in the region: SunAllomer in Japan (16.7%), PolyMirae in South Korea (10%) and HMC Polymers Company in Thailand (5%).

The transactions are expected to be completed in August.

“Basell and its predecessor companies have had an excellent shareholder relationship with TPP for more than three decades,” said Ian Dunn, president of Basell International, “and TPP has had a very good track record. The decision to sell was not an easy one, but we believe this path forward is best for the long-term future of TPP. It is also consistent with Basell’s strategic intent to focus in areas where we have built advantaged feedstock positions.”

Dunn added: “The opportunity to increase our shareholding in HMC, PolyMirae and SunAllomer will better position Basell to support the further development of these companies in the strategically important Asia Pacific region.”

Lee Chang Yung Chemical Industry Corporation is a leading global thermoplastic elastomer manufacturer. Established in 1966, its head office is in Taipei City.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.